The 22 projects, all using mRNA technology, are led by some of the nation's leading pharmaceutical companies to prevent flu, ...

The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health experts who call it "dangerous." ...

A Stanford-led study found that children facing a rare, deadly flu complication involving brain swelling and runaway immune responses may have better chances of recovery with rapid, targeted care ...

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its biomedical research unit.

HHS Secretary Robert F. Kennedy Jr. announced the agency will pull $500 million in funding for mRNA vaccine development programs. Experts explain how this move impacts public health.

BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.

The ACT is experiencing its worst flu season to date with the number of cases surpassing the record set in 2024. Lucy is the city reporter for The Canberra Times, covering business, hospitality, ...

However, the AAP addressed the safety of thimerosal-containing vaccines in its flu vaccine recommendations, and in a recent FactChecked article.

The threat of another influenza pandemic arising from bird-to-human and then human-to-human transmission drives continuing efforts to develop effective vaccines against avian influenza. In the latest ...

You may already have some protection from bird flu, but don’t count on it Antibodies from past H1N1 or H3N2 infections or vaccines show limited defense against H5N1 ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has approved a major Centers for Disease Control & Prevention recommendation to remove mercury-based thimerosal from all flu vaccines ...